AMRN
Amarin Corporation plc
Price Chart
Latest Quote
$14.99
Current Price| Previous Close | $14.92 |
| Open | $14.89 |
| Day High | $15.32 |
| Day Low | $14.76 |
| Volume | 49,593 |
Stock Information
| Shares Outstanding | 20.79M |
| Total Debt | $9.03M |
| Cash Equivalents | $286.59M |
| Revenue | $226.73M |
| Net Income | $-86.19M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | $311.79M |
| EPS (TTM) | $-4.20 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 14/42| Debt to Equity | 0.02 |
| Debt to Earnings | 0.09 |
| Current Ratio | 3.31 |
| Quick Ratio | 2.31 |
| Avg Revenue Growth | -15.20% |
| Profit Margin | -35.95% |
| Return on Equity | -16.90% |
| Avg FCF Growth | -13.34% |
| FCF Yield | -9.95% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $15.00 | 49,800 |
| 2026-01-30 | $14.92 | 52,800 |
| 2026-01-29 | $15.42 | 61,600 |
| 2026-01-28 | $15.07 | 65,600 |
| 2026-01-27 | $15.69 | 35,800 |
| 2026-01-26 | $15.55 | 89,400 |
| 2026-01-23 | $16.26 | 138,700 |
| 2026-01-22 | $16.51 | 142,300 |
| 2026-01-21 | $15.29 | 106,700 |
| 2026-01-20 | $15.51 | 134,400 |
| 2026-01-16 | $14.78 | 77,100 |
| 2026-01-15 | $14.90 | 74,800 |
| 2026-01-14 | $15.01 | 131,300 |
| 2026-01-13 | $15.16 | 74,800 |
| 2026-01-12 | $15.56 | 152,900 |
| 2026-01-09 | $15.82 | 114,400 |
| 2026-01-08 | $16.40 | 252,700 |
| 2026-01-07 | $14.03 | 45,100 |
| 2026-01-06 | $13.69 | 64,200 |
| 2026-01-05 | $13.50 | 55,300 |
About Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
đ° Latest News
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Up for Week
MT Newswires âĸ 2026-01-30T16:14:34ZNew Strong Sell Stocks for January 28th
Zacks âĸ 2026-01-28T10:39:00Z
How Shifting Price Targets Are Rewriting The Amarin (AMRN) Investment Story
Simply Wall St. âĸ 2026-01-27T16:07:19Z
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week
MT Newswires âĸ 2026-01-23T16:06:21ZBioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-01-22T15:28:00Z
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires âĸ 2026-01-21T16:16:41ZDo Options Traders Know Something About Amarin Stock We Don't?
Zacks âĸ 2026-01-20T13:34:00Z
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights
Insider Monkey âĸ 2026-01-10T19:57:10Z
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations
Zacks âĸ 2026-01-09T16:46:00Z
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
MT Newswires âĸ 2026-01-08T16:02:33ZIncome Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $147,232,000 | $141,370,000 | $126,709,000 | $121,327,000 |
| Cost Of Revenue | $147,232,000 | $141,370,000 | $126,709,000 | $121,327,000 |
| Total Revenue | $228,614,000 | $306,911,000 | $369,193,000 | $583,187,000 |
| Operating Revenue | $228,614,000 | $306,911,000 | $369,193,000 | $583,187,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $7,000 | $8,000 | $15,000 | $129,000 |
| Total Expenses | $320,411,000 | $363,527,000 | $461,536,000 | $558,968,000 |
| Other Income Expense | $1,201,000 | $-8,909,000 | $-14,266,000 | $-14,019,000 |
| Other Non Operating Income Expenses | $1,201,000 | $2,063,000 | $-740,000 | $-302,000 |
| Net Non Operating Interest Income Expense | $13,396,000 | $11,855,000 | $2,804,000 | $1,091,000 |
| Interest Expense Non Operating | $7,000 | $8,000 | $15,000 | $129,000 |
| Operating Expense | $173,179,000 | $222,157,000 | $334,827,000 | $437,641,000 |
| Selling And Marketing Expense | $79,587,000 | $111,326,000 | $185,614,000 | $266,474,000 |
| General And Administrative Expense | $72,723,000 | $88,612,000 | $118,802,000 | $141,860,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Net Interest Income | $13,396,000 | $11,855,000 | $2,804,000 | $1,091,000 |
| Interest Income | $13,403,000 | $11,863,000 | $2,819,000 | $1,220,000 |
| Normalized Income | $-82,183,000 | $-50,444,120 | $-95,117,460 | $17,118,664 |
| Net Income From Continuing And Discontinued Operation | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Total Operating Income As Reported | $-91,797,000 | $-67,588,000 | $-105,869,000 | $10,502,000 |
| Net Income Common Stockholders | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Net Income | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Net Income Including Noncontrolling Interests | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Net Income Continuous Operations | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Pretax Income | $-77,200,000 | $-53,670,000 | $-103,805,000 | $11,291,000 |
| Special Income Charges | $0 | $-10,972,000 | $-13,526,000 | $-13,717,000 |
| Interest Income Non Operating | $13,403,000 | $11,863,000 | $2,819,000 | $1,220,000 |
| Operating Income | $-91,797,000 | $-56,616,000 | $-92,343,000 | $24,219,000 |
| Gross Profit | $81,382,000 | $165,541,000 | $242,484,000 | $461,860,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-4.00 | $-3.00 | $-5.20 | $0.40 |
| Basic EPS | $-4.00 | $-3.00 | $-5.20 | $0.40 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $-2,304,120 | $-2,840,460 | $-4,327,336 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-74,180,000 | $-39,725,000 | $-87,168,000 | $27,994,000 |
| Total Unusual Items | $0 | $-10,972,000 | $-13,526,000 | $-13,717,000 |
| Total Unusual Items Excluding Goodwill | $0 | $-10,972,000 | $-13,526,000 | $-13,717,000 |
| Reconciled Depreciation | $3,013,000 | $2,965,000 | $3,096,000 | $2,857,000 |
| EBITDA (Bullshit earnings) | $-74,180,000 | $-50,697,000 | $-100,694,000 | $14,277,000 |
| EBIT | $-77,193,000 | $-53,662,000 | $-103,790,000 | $11,420,000 |
| Diluted Average Shares | $20,546,850 | $20,382,750 | $20,057,750 | $20,124,000 |
| Basic Average Shares | $20,546,850 | $20,382,750 | $20,057,750 | $19,799,600 |
| Diluted NI Availto Com Stockholders | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Tax Provision | $4,983,000 | $5,442,000 | $1,998,000 | $3,562,000 |
| Restructuring And Mergern Acquisition | $0 | $10,972,000 | $13,526,000 | $13,717,000 |
| Research And Development | $20,869,000 | $22,219,000 | $30,411,000 | $29,307,000 |
| Selling General And Administration | $152,310,000 | $199,938,000 | $304,416,000 | $408,334,000 |
| Other Gand A | $58,557,000 | $76,119,000 | $96,462,000 | $109,555,000 |
| Salaries And Wages | $14,166,000 | $12,493,000 | $22,340,000 | $32,305,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $469,787,000 | $532,793,000 | $573,553,000 | $643,552,000 |
| Total Assets | $685,349,000 | $831,684,000 | $886,179,000 | $1,068,065,000 |
| Total Non Current Assets | $89,950,000 | $106,703,000 | $197,081,000 | $189,338,000 |
| Other Non Current Assets | $65,953,000 | $78,975,000 | $164,078,000 | $121,710,000 |
| Goodwill And Other Intangible Assets | $16,389,000 | $19,304,000 | $21,780,000 | $23,547,000 |
| Other Intangible Assets | $16,389,000 | $19,304,000 | $21,780,000 | $23,547,000 |
| Current Assets | $595,399,000 | $724,981,000 | $689,098,000 | $878,727,000 |
| Other Current Assets | $12,552,000 | $11,618,000 | $19,492,000 | $22,352,000 |
| Restricted Cash | $300,000 | $525,000 | $523,000 | $3,918,000 |
| Inventory | $166,048,000 | $258,616,000 | $228,732,000 | $234,676,000 |
| Receivables | $122,279,000 | $133,563,000 | $130,990,000 | $163,653,000 |
| Accounts Receivable | $122,279,000 | $133,563,000 | $130,990,000 | $163,653,000 |
| Allowance For Doubtful Accounts Receivable | $-10,793,000 | $-27,123,000 | $-56,428,000 | $-99,295,000 |
| Gross Accounts Receivable | $133,072,000 | $160,686,000 | $187,418,000 | $262,948,000 |
| Cash Cash Equivalents And Short Term Investments | $294,220,000 | $320,659,000 | $309,361,000 | $454,128,000 |
| Cash And Cash Equivalents | $121,038,000 | $199,252,000 | $217,666,000 | $219,454,000 |
| Prepaid Assets | - | - | - | $22,352,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $7,723,000 | $8,737,000 | $10,015,000 | $8,576,000 |
| Long Term Debt And Capital Lease Obligation | $7,723,000 | $8,737,000 | $10,015,000 | $8,576,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $199,173,000 | $279,587,000 | $290,846,000 | $400,966,000 |
| Total Non Current Liabilities Net Minority Interest | $19,224,000 | $20,310,000 | $31,367,000 | $30,284,000 |
| Other Non Current Liabilities | $11,501,000 | $9,064,000 | $8,205,000 | $7,648,000 |
| Non Current Deferred Liabilities | $0 | $2,509,000 | $13,147,000 | $14,060,000 |
| Current Liabilities | $179,949,000 | $259,277,000 | $259,479,000 | $370,682,000 |
| Other Current Liabilities | $17,545,000 | $23,022,000 | $35,643,000 | $45,602,000 |
| Current Deferred Liabilities | $0 | $2,341,000 | $2,199,000 | $2,649,000 |
| Payables And Accrued Expenses | $162,404,000 | $233,914,000 | $221,637,000 | $322,431,000 |
| Payables | $40,366,000 | $52,762,000 | $64,602,000 | $114,922,000 |
| Accounts Payable | $40,366,000 | $52,762,000 | $64,602,000 | $114,922,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $486,176,000 | $552,097,000 | $595,333,000 | $667,099,000 |
| Total Equity Gross Minority Interest | $486,176,000 | $552,097,000 | $595,333,000 | $667,099,000 |
| Stockholders Equity | $486,176,000 | $552,097,000 | $595,333,000 | $667,099,000 |
| Retained Earnings | $-1,668,546,000 | $-1,586,363,000 | $-1,527,251,000 | $-1,421,448,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $10,672,049 | $9,317,202 | $7,986,831 | $7,486,767 |
| Ordinary Shares Number | $411,584,851 | $408,824,093 | $404,346,256 | $396,598,008 |
| Share Issued | $422,256,900 | $418,141,295 | $412,333,087 | $404,084,775 |
| Tangible Book Value | $469,787,000 | $532,793,000 | $573,553,000 | $643,552,000 |
| Invested Capital | $486,176,000 | $552,097,000 | $595,333,000 | $667,099,000 |
| Working Capital | $415,450,000 | $465,704,000 | $429,619,000 | $508,045,000 |
| Capital Lease Obligations | $7,723,000 | $8,737,000 | $10,015,000 | $8,576,000 |
| Total Capitalization | $486,176,000 | $552,097,000 | $595,333,000 | $667,099,000 |
| Treasury Stock | $65,326,000 | $63,752,000 | $61,770,000 | $60,726,000 |
| Additional Paid In Capital | $1,914,750,000 | $1,899,456,000 | $1,885,352,000 | $1,855,246,000 |
| Capital Stock | $305,298,000 | $302,756,000 | $299,002,000 | $294,027,000 |
| Common Stock | $305,298,000 | $302,756,000 | $299,002,000 | $294,027,000 |
| Non Current Deferred Revenue | $0 | $2,509,000 | $13,147,000 | $14,060,000 |
| Long Term Capital Lease Obligation | $7,723,000 | $8,737,000 | $10,015,000 | $8,576,000 |
| Current Deferred Revenue | $0 | $2,341,000 | $2,199,000 | $2,649,000 |
| Current Accrued Expenses | $122,038,000 | $181,152,000 | $157,035,000 | $207,509,000 |
| Net PPE | $7,608,000 | $8,424,000 | $9,948,000 | $9,085,000 |
| Accumulated Depreciation | $-1,470,000 | $-1,379,000 | $-2,472,000 | $-1,921,000 |
| Gross PPE | $9,078,000 | $9,803,000 | $12,420,000 | $11,006,000 |
| Leases | $217,000 | $217,000 | $869,000 | $869,000 |
| Other Properties | $7,592,000 | $8,310,000 | $9,074,000 | $7,660,000 |
| Machinery Furniture Equipment | $1,269,000 | $1,276,000 | $2,477,000 | $2,477,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $173,182,000 | $121,407,000 | $91,695,000 | $234,674,000 |
| Investments And Advances | - | $0 | $1,275,000 | $34,996,000 |
| Buildings And Improvements | - | - | $9,074,000 | $7,660,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-31,020,000 | $6,347,000 | $-180,691,000 | $-66,537,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-31,020,000 | $6,880,000 | $-180,092,000 | $-66,537,000 |
| Cash Flow From Continuing Operating Activities | $-31,020,000 | $6,880,000 | $-180,092,000 | $-66,537,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Investing Cash Flow | $-45,976,000 | $-25,522,000 | $175,288,000 | $104,103,000 |
| Cash Flow From Continuing Investing Activities | $-45,976,000 | $-25,522,000 | $175,288,000 | $104,103,000 |
| Capital Expenditure | - | $-533,000 | $-599,000 | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Financing Cash Flow | $-1,443,000 | $230,000 | $-379,000 | $-5,073,000 |
| Cash Flow From Continuing Financing Activities | $-1,443,000 | $230,000 | $-379,000 | $-5,073,000 |
| Net Other Financing Charges | $-1,574,000 | $-1,982,000 | $-1,044,000 | $-9,644,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Income Tax Paid Supplemental Data | $3,982,000 | $2,367,000 | $1,782,000 | - |
| End Cash Position | $121,338,000 | $199,777,000 | $218,189,000 | $223,372,000 |
| Beginning Cash Position | $199,777,000 | $218,189,000 | $223,372,000 | $190,879,000 |
| Changes In Cash | $-78,439,000 | $-18,412,000 | $-5,183,000 | $32,493,000 |
| Proceeds From Stock Option Exercised | $131,000 | $2,212,000 | $665,000 | $4,571,000 |
| Net Investment Purchase And Sale | $-45,976,000 | $-24,989,000 | $175,887,000 | $104,099,000 |
| Sale Of Investment | $232,800,000 | $190,108,000 | $257,520,000 | $394,294,000 |
| Purchase Of Investment | $-278,776,000 | $-215,097,000 | $-81,633,000 | $-290,195,000 |
| Net Intangibles Purchase And Sale | $0 | $-509,000 | $-599,000 | $0 |
| Purchase Of Intangibles | $0 | $-509,000 | $-599,000 | $0 |
| Net PPE Purchase And Sale | $0 | $-24,000 | $0 | $4,000 |
| Purchase Of PPE | $0 | $-24,000 | $0 | - |
| Change In Working Capital | $36,174,000 | $51,077,000 | $-104,071,000 | $-115,990,000 |
| Change In Other Working Capital | $-4,850,000 | $-10,496,000 | $-1,363,000 | $-1,923,000 |
| Change In Other Current Liabilities | $2,141,000 | $345,000 | $581,000 | $1,253,000 |
| Change In Other Current Assets | $147,000 | $-278,000 | $-2,000 | $-24,000 |
| Change In Payables And Accrued Expense | $-76,987,000 | $-164,000 | $-102,729,000 | $51,516,000 |
| Change In Payable | $-76,987,000 | $-164,000 | $-102,729,000 | $51,516,000 |
| Change In Account Payable | $-76,987,000 | $-164,000 | $-102,729,000 | $51,516,000 |
| Change In Prepaid Assets | $-934,000 | $7,874,000 | $2,860,000 | $8,595,000 |
| Change In Inventory | $105,443,000 | $56,121,000 | $-36,422,000 | $-167,066,000 |
| Change In Receivables | $11,214,000 | $-2,325,000 | $33,004,000 | $-8,341,000 |
| Changes In Account Receivables | $11,284,000 | $-2,573,000 | $32,663,000 | $-9,079,000 |
| Stock Based Compensation | $17,705,000 | $15,646,000 | $26,213,000 | $36,938,000 |
| Amortization Of Securities | $-5,729,000 | $-3,696,000 | $473,000 | $1,929,000 |
| Depreciation Amortization Depletion | $3,013,000 | $2,965,000 | $3,096,000 | $2,857,000 |
| Depreciation And Amortization | $3,013,000 | $2,965,000 | $3,096,000 | $2,857,000 |
| Amortization Cash Flow | $2,915,000 | $2,805,000 | $2,545,000 | $2,270,000 |
| Amortization Of Intangibles | $2,915,000 | $2,805,000 | $2,545,000 | $2,270,000 |
| Depreciation | $98,000 | $160,000 | $551,000 | $587,000 |
| Net Income From Continuing Operations | $-82,183,000 | $-59,112,000 | $-105,803,000 | $7,729,000 |
| Repayment Of Debt | - | - | $0 | $0 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Net Issuance Payments Of Debt | - | - | $0 | $0 |
| Net Long Term Debt Issuance | - | - | $0 | $0 |
| Long Term Debt Payments | - | - | $0 | $0 |
| Change In Accrued Expense | - | - | $0 | $0 |
| Change In Interest Payable | - | - | $0 | $0 |